Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Training | 2022
Harm reduction, About prescribers, Illegal drugs
Morphine preparations are known to have small amounts of codeine as an impurity estimated to be about 0.04%
Original research | 2009
Drug checking, Substitution/OAT
Case study | 2022
Safer supply, About prescribers, Policy/Regulatory, Wrap-around services, Barriers and enablers, Evidence base, Social services, Harm reduction
Commentary | 2022
Safer supply, About PWUD, Social benefits
Integrating the social-ecological framework, we focus on individual characteristics, personal and family members' experience with OUD, and spatial access to OUD at the community level.
Original research | 2022
Stigma
The purpose of this paper is to provide findings related to two research questions: first,do low-threshold employment programmes have the potential to contribute to positive recovery capital, and i
Original research | 2016
Peer/PWLLE program involvement
This paper asks, what values do people who use drugs hold surrounding drug use and drug policy, and what factors predict these values?
Original research | 2022
About PWUD, Policy/Regulatory
We estimated the impact of OAT on hospitalisations for non-viral infections and examine trends in incidence over time.
Original research | 2022
Substitution/OAT, Injecting drugs, About PWUD, Outcomes, Illegal drugs, Hospitals
Slide deck | 2022
Hospitals, Harm reduction, Policy/Regulatory, Stigma
This study examines whether hospital admission and discharge are associated with increased risk of opioid-related death.
Original research | 2021
Overdose, Mortality, About PWUD, Hospitals
Commentary | 2021
Harm reduction, Policy/Regulatory, Barriers and enablers, Peer/PWLLE program involvement, SCS/OPS, Hospitals
Guidelines | 2020
Clinical guidance, Advocacy, Barriers and enablers, Hospitals, About prescribers
This analysis used U.S. Drug Enforcement Administration (DEA) data to address two questions: (1) To what extent does illegally manufactured fentanyl (IMF) supply vary over time and geography?
Original research | 2022
Drug checking, Illegal drugs
This review aimed to examine the impact and acceptability of community-based models of alcohol and other drug (AOD) support for First Nations adults in Australia.
Lit review | 2022
Indigenous, Wrap-around services
Video | 2022
Hospitals, Stigma, Policy/Regulatory, Harm reduction
We designed this study to analyze the prevalence, nature, and context of beliefs about naloxone and overdose among U.S. laypersons.
Original research | 2022
Overdose, Advocacy
We evaluated: (1) punitive prenatal substance use policies (PSUPs) criminalizing prenatal substance use or defining it as child maltreatment; (2) supportive PSUPs granting pregnant females priority
Original research | 2022
Parents/caregivers, Policy/Regulatory, About PWUD, Barriers and enablers, Sex/Gender
People admitted to compulsory care are known to suffer high mortality risks, but whether the risk of dying is further heightened immediately after discharge is not known.
Original research | 2022
Transitions in care/treatment, About PWUD, Mortality, Policy/Regulatory, Outcomes
The purpose of this study was to qualitatively assess how efforts to increase access to buprenorphine via telehealth are implemented by prescribers and pharmacists and experienced by patients.
Original research | 2022
Policy/Regulatory, About PWUD, About pharmacists, Barriers and enablers, Transitions in care/treatment, Digital health, Stigma
In 2017, the Good Samaritan Drug Overdose Act (GSDOA) was enacted, to encourage people to contact emergency medical services by providing bystanders at the scene of an overdose with legal protectio
Original research | 2022
Overdose, Legal system/law enforcement, Policy/Regulatory, Equity, Decriminalization/legalization, Barriers and enablers
